1. Home
  2. ARDX vs PRSU Comparison

ARDX vs PRSU Comparison

Compare ARDX & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$4.05

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$46.15

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
PRSU
Founded
2007
1926
Country
United States
United States
Employees
N/A
2100
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
PRSU
Price
$4.05
$46.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$15.14
$31.67
AVG Volume (30 Days)
2.6M
214.1K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,607,000.00
N/A
Revenue This Year
$37.75
$4.85
Revenue Next Year
$34.24
$4.94
P/E Ratio
N/A
$3.45
Revenue Growth
N/A
N/A
52 Week Low
$4.71
$32.03
52 Week High
$8.40
$56.52

Technical Indicators

Market Signals
Indicator
ARDX
PRSU
Relative Strength Index (RSI) 34.44 34.34
Support Level N/A $32.90
Resistance Level $6.47 $54.24
Average True Range (ATR) 0.16 1.83
MACD 0.01 -0.61
Stochastic Oscillator 12.09 6.94

Price Performance

Historical Comparison
ARDX
PRSU

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, Iceland and Costa Rica. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

Share on Social Networks: